Sort   by:  
 Page size 

OBJECTIVES: High activity of Indoleamine 2,3-dioxygenase1 (IDO1) in lung cancer patients converts tryptophan (Trp), which is the essential amino acid for T cell metabolism, to kynurenine (Kyn) and consequently suppresses anti-tumor immune responses. We aimed to track the dynamics...

2022-08-05 | MTBLS5267 | MetaboLights
IDO1 interacting proteins in two colorectal cancer cells and was subjected to beads, and the beads were washed by buffer and identified by mass spectrometry (MS)
ORGANISM(S): Homo Sapiens 
2022-05-05 | PXD033718 |
Identification of IDO1 depedent genes upon IFN-γ stimulation
An adverse tumor-protective effect of IDO1 inhibition
Analysis of HeLa cell transcriptome changes induced by IDO1-metabolism
Gestational gut microbiome-IDO1 axis mediates pregnancy insulin resistance
IDO1 overexpression significantly affects exosomal miRNA subsets derived from osteosarcoma and ordinary osteoblasts
A key mechanism of malignant cell evasion from anti-tumor immunity centers on tryptophan metabolism by indole-2,3-dioxygenase (IDO1). By degrading tryptophan, IDO1 impairs anti-tumor T cell responses, which should be restored by IDO1 inhibitors (IDO1i). All IDO1i have, however, failed their clinical...
ORGANISM(S): Homo sapiens 
2026-01-20 | GSE307099 | GEO
Tumor endothelial up-regulation of IDO1 limits the response to CD40-stimulating immunotherapy
Identification of indoleamine 2, 3-dioxygenase 1 (IDO1) regulated genes in human glioblastoma cell line U87
Sort   by:  
 Page size